Oxidative alkylamination of azinones as a direct route to aminoazinones: study of some condensed diazinones

Tetrahedron

Volumn 64, Issue 4, 2008, Pages 696-707

  Gulevskaya, Anna V ^a   Burov, Oleg N ^a   Pozharskii, Alexander F ^a   Kletskii, Mikhail E ^a   Korbukova, Inna N ^a  

^a SOUTHERN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

Alkylaminoazinones; Azinones; Nucleophilic aromatic substitution of hydrogen; Oxidative alkylamination

Indexed keywords

1 METHYLQUINOXALIN 2(1H) ONE; 1,3 DIMETHYLPTERIDIN 2,4,6(1H,3H,6H) TRIONE; 1,3,6 TRIMETHYLPYRIMIDO[4,5 D]PYRIMIDIN 2,4,7(1H,3H,6H) TRIONE; 6,8 DIMETHYLPYRIMIDO[4,5 C]PYRADAZIN 3,5,7(2H,6H,8H) TRIONE; ACICLOVIR; ALIPHATIC AMINE; AMINOAZINONE; AZINONE; BROPIRIMINE; CYTOSINE; DIAZINONE; GUANINE; LAMIVUDINE; PERMANGANATE POTASSIUM; PTERIDINE DERIVATIVE; PYRIDAZINONE DERIVATIVE; PYRIMIDINE DERIVATIVE; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG; ZALCITABINE;

AMINATION; AROMATIZATION; ARTICLE; CHEMICAL STRUCTURE; CYCLIZATION; HYDROLYSIS; OXIDATION; PRIORITY JOURNAL; REACTION ANALYSIS; ROOM TEMPERATURE; SUBSTITUTION REACTION;

EID: 36849003528     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.11.029     Document Type: Article

References (58)

1. 3-Amino- and 3-alkylaminopyrazin-2-ones, synthesis and antithrombotic activity:
2. Nantermet P.G., and Selnick H.G. Tetrahedron Lett. 44 (2003) 2401
3. Burgey C.S., Robinson K.A., Lyle T.A., Nantermet P.G., Selnick H.G., Isaacs R.C.A., Dale Lewis S., Lucas B.J., Krueger J.A., Singh R., Miller-Stein C., White R.B., Wong B., Lyle E.A., Stranieri M.T., Cook J.J., McMasters D.R., Pellicore J.M., Pal S., Wallace A.A., Clayton F.C., Bohn D., Welsh D.C., Lynch Jr. J.J., Yan Y., Chen Z., Kuo L., Gardell S.J., Shafer J.A., and Vacca J.P. Bioorg. Med. Chem. Lett. 13 (2003) 1353
4. Sanderson P.E.J., Lyle T.A., Cutrona K.J., Dyer D.L., Dorsey B.D., McDonough C.M., Naylor-Olsen A.M., Chen I.-W., Chen Z., Cook J.J., Cooper C., Gardell S.J., Hare T.R., Krueger J.A., Dale Lewis S., Lin J.H., Lucas B.J., Lyle E.A., Lynch Jr. J.J., Stranieri M.T., Vastag K., Yan Y., Shafer J.A., and Vacca J.P. J. Med. Chem. 41 (1998) 4466
5. Isabel E., Aspiotis R., Black W.C., Colucci J., Fortin R., Giroux A., Grimm E.L., Han Y., Mellon C., Nicholson D.W., Rasper D.M., Renaud J., Roy S., Tam J., Tawa P., Vaillancourt J.P., Xanthoudakis S., and Zamboni R.J. Bioorg. Med. Chem. Lett. 17 (2007) 1671
6. Kuse M., Kondo N., Ohyabu Y., and Isobe M. Tetrahedron 60 (2004) 835
7. Chung J.Y.L., Cvetovich R.J., Tsay F.-R., Dormer P.G., DiMichele L., Mathre D.J., Chilenski J.R., Mao B., and Wenslow R. J. Org. Chem. 68 (2003) 8838
8. Isaacs R.C.A., Solinsky M., Cutrona K.J., Newton C.L., Naylor-Olsen A.M., Krueger J.A., Dale Lewis S., and Lucas B.J. Bioorg. Med. Chem. Lett. 16 (2006) 338
9. Nantermet P.G., Burgey C.S., Robinson K.A., Pellicore J.M., Newton C.L., Deng J.Z., Selnick H.G., Dale Lewis S., Lucas B.J., Krueger J.A., Miller-Stein C., White R.B., Wong B., McMasters D.R., Wallace A.A., Lynch Jr. J.J., Yan Y., Chen Z., Kuo L., Gardell S.J., Shafer J.A., Vacca J.P., and Lyle T.A. Bioorg. Med. Chem. Lett. 15 (2005) 2771
10. 4(5)-Amino- and 4(5)-alkylaminopyridazin-3-ones, synthesis, anti-arrhythmic properties and in vitro ability to inhibit aldose reductase (ALR2):
11. Dal Piaz V., Vergelli C., Giovannoni M.P., Scheideler M.A., Petrone G., and Zaratin P. Il Farmaco 58 (2003) 1063
12. Costantino L., Rastelli G., Gamberini M.C., Giovannoni M.P., Dal Piaz V., Vianello P., and Barlocco D. J. Med. Chem. 42 (1999) 1894
13. Károlyházy L., Szabó D., Anwair M.A.S., Borosy A.P., Takács-Novák K., and Mátyus P. J. Mol. Struct. (Theochem) 578 (2002) 89
14. Anwair M.A.S., Károlyházy L., Szabó D., Balogh B., Kovesdi I., Harmat V., Krenyácz J., Gellért A., Takács-Novák K., and Mátyus P. J. Agric. Food Chem. 51 (2003) 5262
15. 3-Amino- and 3-alkylaminoquinoxalin-2(1H)-ones, synthesis and CNS activity:
16. Csikós E., Gönczi C., Podányi B., Tóth G., and Hermecz I. J. Chem. Soc., Perkin Trans. 1 (1999) 1789
17. Moustafa O.S. J. Chin. Chem. Soc. 47 (2000) 351
18. 2-Amino- and 2-alkylaminoquinazolin-4(3H)-ones, synthesis, hypotensive activity and ability to inhibit the glucose-induced insulin release:
19. Somers F., Ouedraogo R., Antoine M.-H., De Tullio P., Becker B., Fontaine J., Damas J., Dupont L., Rigo B., Delarge J., Lebrune P., and Pirotte B. J. Med. Chem. 44 (2001) 2575
20. Hess H.J., Cronin T.H., and Scriabine A. J. Med. Chem. 11 (1968) 130
21. Kundu B., Partani P., Duggineni S., and Sawant D. J. Comb. Chem. 7 (2005) 909
22. Connoly D., Cusack D., O'Sullivan T.P., and Guiry P.J. Tetrahedron 61 (2005) 10153
23. 2-Amino- and 2-arylaminopyrimidin-4(3H)-ones, synthesis and biological activity:
24. Hannah D.R., Sherer E.C., Davies R.V., Titman R.B., Laughton C.A., and Stevens M.F.G. Bioorg. Med. Chem. 8 (2000) 739
25. Rose Y., Ciblat S., Reddy R., Belley A.C., Dietrich E., Lehoux D., McKay G.A., Poirier H., Rafai Far A., and Delorme D. Bioorg. Med. Chem. Lett. 16 (2006) 891 4-Alkylaminopyrimidin-2(1H)-ones:
26. Zechel C., Backfisch G., Delzer J., Geneste H., Graef C., Hornberger W., Kling A., Lange U.E.W., Lauterbach A., Seitz W., and Subkowski T. Bioorg. Med. Chem. Lett. 12 (2002) 165 5-Alkylaminopyrimidin-4(3H)-ones:
27. Akahoshi F., Ashimori A., Yoshimura T., Imada T., Nakajiama M., Mitsutomi N., Kuwahara S., Ohtsuka T., Fukaya C., Miyazaki M., and Nakamura N. Bioorg. Med. Chem. 9 (2001) 301 5-Aminopyrimidin-2(1H)-ones:
28. Luo G. Tetrahedron Lett. 45 (2004) 8331
29. Gulevskaya A.V., Besedin D.V., and Pozharskii A.F. Russ. Chem. Bull., Int. Ed. 48 (1999) 1150
30. Besedin D.V., Gulevskaya A.V., and Pozharskii A.F. Mendeleev Commun. 10 (2000) 150
31. Gorunenko V.V., Gulevskaya A.V., and Pozharskii A.F. Russ. Chem. Bull., Int. Ed. 53 (2004) 846
32. Van der Plas H.C. Adv. Heterocycl. Chem. 86 (2004) 1
33. 4 at the oxidative alkylamination, see:
34. Gulevskaya A.V., Maes B.U.W., Meyers C., Herrebout W.A., and Van der Veken B.J. Eur. J. Org. Chem. (2006) 5305
35. Katritzky A.R., and Pozharskii A.F. Handbook of Heterocyclic Chemistry. 2nd ed. (2000), Pergamon, Amsterdam pp 43-52, 195-220, 272-276
36. Coates W.J., and McKillop A. Heterocycles 29 (1989) 1077
37. Coates W.J., and McKillop A. Heterocycles 35 (1993) 1313
38. Ostrowicz A., Bałoniak S., Ma{ogonek}kosza M., and Rykowski A. Tetrahedron Lett. 33 (1992) 4787
39. Chupakhin O.N., Sidorov E.O., and Postovskii I.J. Chem. Heterocycl. Compd. (Engl. Transl.) 10 (1974) 867
40. Bojarska-Dahlig H., and Nautka-Namirski P. Roczniki Chemii 30 (1956) 461
41. Chem. Abstr. 51 (1957) 14722
42. Chichibabin, A. E. Germany Patent 374291;
43. Chem. Abstr. 18 (1924) 2176
44. Becke A.D. J. Chem. Phys. 98 (1993) 5648
45. Lee C., Yang W., and Parr R.G. Phys. Rev. B 37 (1988) 785
46. Hehre W.J., Radom L., Schleyer P.V.R., and Pople J.A. Ab initio Molecular Orbital Theory (1986), Wiley, New York, NY
47. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Montgomery Jr. J.A., Vreven T., Kudin K.N., Burant J.C., Millam J.M., Iyengar S.S., Tomasi J., Barone V., Mennucci B., Cossi M., Scalmani G., Rega N., Petersson G.A., Nakatsuji H., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Klene M., Li X., Knox J.E., Hratchian H.P., Cross J.B., Bakken V., Adamo C., Jaramillo J., Gomperts R., Stratmann R.E., Yazyev O., Austin A.J., Cammi R., Pomelli C., Ochterski J.W., Ayala P.Y., Morokuma K., Voth G.A., Salvador P., Dannenberg J.J., Zakrzewski V.G., Dapprich S., Daniels A.D., Strain M.C., Farkas O., Malick D.K., Rabuck A.D., Raghavachari K., Foresman J.B., Ortiz J.V., Cui Q., Baboul A.G., Clifford S., Cioslowski J., Stefanov B.B., Liu G., Liashenko A., Piskorz P., Komaromi I., Martin R.L., Fox D.J., Keith T., Al-Laham M.A., Peng C.Y., Nanayakkara A., Challacombe M., Gill P.M.W., Johnson B., Chen W., Wong M.W., Gonzalez C., and Pople J.A. Gaussian 03, revision C.01 (2004), Gaussian, Wallingford CT
48. N(k) is the electron density at a point k in space around the molecule, N corresponds to the number of electrons in the neutral molecule and N+1 refers to the number of electrons in the corresponding radical anion (obtained by adding an electron to the LUMO of the neutral molecule).
49. Parr R.G., von Szetpaly L., and Liu S. J. Am. Chem. Soc. 121 (1999) 1922
50. Parr R.G., and Pearson R.G. J. Am. Chem. Soc. 105 (1983) 7512
51. Domingo L.R., Aurell M.J., Pérez P., and Contreras R. J. Phys. Chem. A 106 (2002) 6871
52. Domingo L.R., Aurell M.J., Pérez P., and Contreras R. Tetrahedron 59 (2003) 3117
53. Gorunenko V.V., Gulevskaya A.V., and Pozharskii A.F. Russ. Chem. Bull., Int. Ed. 52 (2003) 441
54. Steppan H., Hammer J., Baur R.H., Gotlieb R., and Pfleiderer W. Liebigs Ann. Chem. 67 (1982) 2135
55. Heckel A., and Pfleiderer W. Helv. Chim. Acta 69 (1986) 704
56. Gulevskaya A.V., Pozharskii A.F., Shorshnev S.V., and Zheltushkina E.A. Chem. Heterocycl. Compd. 30 (1994) 1083
57. Bassindale A.R., Parker D.J., Patel P., and Taylor P.G. Tetrahedron Lett. 41 (2000) 4933
58. Nishigaki S., Ichiba M., and Senga K. J. Org. Chem. 48 (1983) 1628